Spliceosome inhibition as a novel therapeutic option in acute leukemia
A Wojtuszkiewicz, R Sciarrillo, G Jansen, YG Assaraf… - Cancer Research, 2016 - AACR
Spliceosome targeting is a novel therapeutic strategy, showing promising results in solid
tumors and hematological malignancies. Aberrant splicing of genes involved in apoptosis …
tumors and hematological malignancies. Aberrant splicing of genes involved in apoptosis …
Different Aspects of Stem Cell Procedures in Children with Poor Responding Aml: When is HSCT the Best Answer?
BM Gustafsson - International Journal of Hematologic Oncology, 2015 - Taylor & Francis
Acute myeloid leukemia in children is a heterogeneous disease with different morphological
and cytogenetic features. New diagnostic tools and treatments, improved supportive care …
and cytogenetic features. New diagnostic tools and treatments, improved supportive care …
[PDF][PDF] Proteasoomremmers bij acute leukemie
D Niewerth - Nederlands Tijdschrift voor Hematologie, 2015 - ariez.nl
Op 14 november 2014 promoveerde D. Niewerth aan de Vrije Universiteit van Amsterdam
op haar promotieonderzoek getiteld:'Proteasoomremmers bij acute leukemie', onder …
op haar promotieonderzoek getiteld:'Proteasoomremmers bij acute leukemie', onder …
Characterization of relapsed Acute Myeloid Leukemia
C Bachas - 2014 - research.vumc.nl
Acute myeloïde leukemie (AML) is een bloedkanker. Circa 30% van kinderen met kanker
heeft leukemie en ongeveer 15% hiervan lijdt aan de variant AML. Onder kinderen komt …
heeft leukemie en ongeveer 15% hiervan lijdt aan de variant AML. Onder kinderen komt …
[PDF][PDF] Exploring Mitochondrial Regulation of Reovirus Infection in Cancer Cells
M Clarkson - 2014 - prism.ucalgary.ca
Oncolytic reovirus demonstrates mixed results in clinical trials. To achieve better clinical
outcomes a more complete understanding of reovirus infection is needed. Efficient reovirus …
outcomes a more complete understanding of reovirus infection is needed. Efficient reovirus …
[PDF][PDF] FAUSTO PEREIRA DOS SANTOS ANEXO DIRETRIZES DIAGNÓSTICAS E TERAPÊUTICAS LEUCEMIA MIELOIDE AGUDA DE CRIANÇAS E …
DDE TERAPÊUTICAS - bvsms.saude.gov.br
A leucemia mieloide aguda (LMA) consiste de um grupo heterogêneo de neoplasias
malignas relacionado com as células hematopoéticas, representando um dos tipos mais …
malignas relacionado com as células hematopoéticas, representando um dos tipos mais …
[PDF][PDF] SECRETARIA DE ATENÇÃO À SAÚDE PORTARIA Nº 840, DE 8 DE SETEMBRO DE 2014
FP DOS SANTOS, DDETL MIELOIDE, A DE - conasems.org.br
1-METODOLOGIA DE BUSCA E AVALIAÇÃO DE LITERATURA Considerando a
heterogeneidade das entidades patológicas que se descrevem como leucemia mieloide …
heterogeneidade das entidades patológicas que se descrevem como leucemia mieloide …
[PDF][PDF] PORTARIA Nº 840, de 08 de setembro de 2014.
FP DOS SANTOS - gov.br
1-METODOLOGIA DE BUSCA E AVALIAÇÃO DE LITERATURA Considerando a
heterogeneidade das entidades patológicas que se descrevem como leucemia mieloide …
heterogeneidade das entidades patológicas que se descrevem como leucemia mieloide …
[PDF][PDF] Aurora Kinase Inhibition as a Novel Therapeutic Approach for the Treatment of Refractory Pediatric and Infant Leukemia
AA Jayanthan - Aurora, 2014 - prism.ucalgary.ca
Leukemia is the most common pediatric malignancy, constituting more than 30% of all
childhood cancers. Although cure rates have improved greatly, approximately one in four …
childhood cancers. Although cure rates have improved greatly, approximately one in four …
Is FLT3 internal tandem duplication an unfavorable risk factor for high risk children with acute myeloid leukemia?: Polish experience
K Pawińska-Wąsikowska, T Książek… - Journal of Cancer …, 2013 - ruj.uj.edu.pl
Is FLT3 Internal Tandem Duplication an Unfavorable Risk Factorfor High Risk Children with
Acute Myeloid Leukemia? – Polish Exp Page 1 246 Journal of Cancer Research Updates …
Acute Myeloid Leukemia? – Polish Exp Page 1 246 Journal of Cancer Research Updates …